07:31 AM EST, 02/18/2025 (MT Newswires) -- Arcus Biosciences ( RCUS ) said Tuesday that it has priced an underwritten offering of 13.6 million shares at $11 per share, for total proceeds of $150 million.

The company said it is selling all of the shares in the offering, which is set to be completed on Wednesday.

Arcus said the proceeds from the offering will be used to fund ongoing research and development, as well as for other general corporate purposes.